Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-13-024039
Filing Date
2013-05-03
Accepted
2013-05-03 20:53:59
Documents
1
Period of Report
2013-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1476
  Complete submission text file 0001209191-13-024039.txt   3177
Mailing Address 12270 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12270 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
Biota Pharmaceuticals, Inc. (Issuer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ADOLOR CORP 700 PENNSYLVANIA DR EXTON PA 19341
Business Address
DOUGHERTY MICHAEL R (Reporting) CIK: 0001033516 (see all company filings)

State of Incorp.: PA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35285 | Film No.: 13814304